Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inactive ubiquitin thioesterase OTULINL (OTULINL) is a protein coding gene in humans, located on the cytoplasmic side of the endoplasmic reticulum membrane and nuclear envelope[2]. It is structurally similar to the deubiquitinase OTULIN (FAM105B), but lacks the conserved catalytic cysteine in the active site, being substituted by an aspartate residue, rendering it catalytically inactive[6][3][7][8]. The molecular structure of OTULINL (FAM105A) reveals deficiencies in both its active site and its substrate binding site, which confirms its classification as a pseudo-deubiquitinase[3][7][8]. Functionally, OTULINL appears to participate in protein-protein interactions rather than ubiquitin cleavage, but the precise biological roles remain unclear. Unlike OTULIN, which has critical roles in immune signaling, cell death, and NF-kB regulation, OTULINL has no established functional role in canonical ubiquitin-dependent processes or disease mechanisms[1][2]. Direct drug interactions, mechanism of action, biomarker utility, or safety issues have not been reported for OTULINL[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inactive ubiquitin thioesterase OTULINL (OTULINL).